Related Experiment Video
Updated: Oct 19, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Myelopathy in sickle cell disease: a case-oriented review
Igor Vilela Brum1, Guilherme Diogo Silva2, Diego Sant'Ana Sodre2
1Department of Neurology, University of São Paulo, São Paulo, Brazil. igor.brum@hc.fm.usp.br.
This study reports the first case of longitudinally extensive myelitis (LETM) in sickle cell disease (SCD), highlighting LETM as a potential cause of myelopathy in these patients.
Area of Science:
- Neurology
- Hematology
- Spinal Cord Medicine
Background:
- Neurological complications are common in sickle cell disease (SCD).
- Myelopathy, particularly compressive and ischemic types, is rarely described in SCD.
- This study introduces longitudinally extensive myelitis (LETM) as a potential neurological complication in SCD.
Observation:
- A 29-year-old man with SCD presented with subacute flaccid paraparesis, urinary retention, and a sensory level.
- Cerebrospinal fluid analysis revealed lymphocytic pleocytosis and elevated protein.
- Spinal MRI showed a T2/STIR hyperintense lesion extending from C2 to T12.
Findings:
- Reviewed literature identified few cases of spinal cord compression and infarction in SCD.
- Only one case of varicella-zoster myelitis was reported.
- This is the first reported case of LETM in a patient with SCD.
Implications:
- LETM should be considered in the differential diagnosis of myelopathy in SCD patients.
- Prompt diagnosis and management of myelopathy are crucial in SCD.
- Recognizing LETM expands the spectrum of spinal cord complications in SCD.
More Related Videos
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Multiple Allele Traits
Peripheral Artery Disease I: Introduction